QSPR and Flow Cytometry Analysis (QSPR-FCA): Review and New Findings on Parallel Study of Multiple Interactions of Chemical Compounds with Immune Cellular and Molecular Targets

Current Drug Metabolism

Volumn 15, Issue 4, 2014, Pages 414-428

  Tenorio Borroto, Esvieta ^a   Ramirez, Fabiola Rivera ^a   Speck Planche, Alejandro ^b   Cordeiro, M Natália D S ^b   Luan, Feng ^b,c   González Díaz, Humberto ^d,e  

^a Universidad Tecnologica Del Valle de Toluca   (Mexico)

^b UNIVERSITY OF PORTO   (Portugal)

^c YANTAI UNIVERSITY   (China)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^e BASQUE FOUNDATION FOR SCIENCE   (Spain)

Author keywords

CD19 lymphocytes; ChEMBL; Complex networks; Drug immunotoxicity; Flow cytometry; Markov chains; Perturbation theory; Spectral moments

Indexed keywords

ANTIINFECTIVE AGENT; CHEMICAL COMPOUND; DERMOFURAL; FURAN DERIVATIVE; PROTEIN; UNCLASSIFIED DRUG; 1-(5-BROMOFUR-2-IL)-2-BROMO-2-NITROETHENE;

CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL LINEAGE; CELL POPULATION; CYTOTOXICITY ASSAY; DATA BASE; DRUG EFFECT; FLOW CYTOMETRY; HELPER CELL; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOTOXICITY; MACROPHAGE; NONHUMAN; PERITONEUM MACROPHAGE; QUANTITATIVE STRUCTURE PROPERTY RELATION; REVIEW; SPLEEN MACROPHAGE; T LYMPHOCYTE; ADVERSE DRUG REACTION; ANIMAL; BIOLOGICAL MODEL; DRUG EFFECTS; FACTUAL DATABASE; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ANIMALS; DATABASES, FACTUAL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FLOW CYTOMETRY; FURANS; HUMANS; IMMUNE SYSTEM; MODELS, BIOLOGICAL; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84925714005     PISSN: 13892002     EISSN: 18755453     Source Type: Journal    
DOI: 10.2174/1389200215666140908101152     Document Type: Review

References (112)

1. Dranoff, G. Immunotherapy at large: Balancing tumor immunity and inflammatory pathology. Nat. Med., 2013, 19, 1100-1101
2. Slovin, S. Chemotherapy and immunotherapy combination in advanced prostate cancer. Clin. Adv. Hematol. Oncol., 2012, 10, 90-100
3. Cao, L.F.; Krymskaya, L.; Tran, V.; Mi, S.; Jensen, M.C.; Blanchard, S.; Kalos, M. Development and application of a multiplexable flow cytometry-based assay to quantify cellmediated cytolysis. Cytometry A., 2010, 77, 534-545
4. Riss, T.L.; Moravec, R.A. Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays. Assay Drug Dev. Technol., 2004, 2, 51-62
5. Mingoia, R.T.; Nabb, D.L.; Yang, C.-H.; Han, X. Primary culture of rat hepatocytes in 96-well plates: Effects of extracellular matrix conWguration on cytochrome P450 enzyme activity and inducibility, and its application in in vitro cytotoxicity screening. Toxicol. in vitro, 2007, 21, 165-173
6. Weyermann J.; Lochmann, D.; Zimmer, A. A practical note on the use of cytotoxicity assays. Int. J. Pharm., 2005, 288, 369-376
7. Kim, K.R.; Son, E.W.; Rhee, D.K.; Pyo, S. The immunomodulatory effects of the herbicide simazine on murine macrophage functions in vitro. Toxicol. in vitro, 2002, 16, 517-523
8. Hamann, J.; Koning, N.; Pouwels, W.; Ulfman, L.H.; van Eijk, M.; Stacey, M.; Lin, H.H.; Gordon, S.; Kwakkenbos, M.J. EMR1, the human homolog of F4/80, is an eosinophil-specific receptor. Eur. J. Immunol., 2007, 37, 2797-2802
9. Koay, D.C.; Sartorelli, A.C. Functional differentiation signals mediated by distinct regions of the cytoplasmic domain of the granulocyte colony-stimulating factor receptor. Blood, 1999, 93, 3774-3784
10. Fischer, M.B.; Ruger, B.; Vaculik, C.; Becherer, A.; Wadsak, W.; Yanagida, G.; Losert, U.M.; Chen, J.; Carroll, M.C.; Eibl, M.M. The presence of MOMA-2+ macrophages in the outer B cell zone and protection of the splenic micro-architecture from LPS-induced destruction depend on secreted IgM. Eur. J. Immunol., 2007, 37, 2825-2833
11. Alatery, A.; Basta, S. An efficient culture method for generating large quantities of mature mouse splenic macrophages. J. Immunol. Methods, 2008, 338, 47-57
12. Marmey, B.; Boix, C.; Barbaroux, J.B.; Dieu-Nosjean, M.C.; Diebold, J.; Audouin, J.; Fridman, W.H.; Mueller, C.G.; Molina, T.J. CD14 and CD169 expression in human lymph nodes and spleen: specific expansion of CD14+CD169-monocyte-derived cells in diffuse large B-cell lymphomas. Hum. Pathol., 2006, 37, 68-77
13. den Haan, J.M.; Kraal, G. Innate Immune Functions of Macrophage Subpopulations in the Spleen. J. Innate Immun., 2012, 4, 437-445
14. Klein, A.B.; Witonsky, S.G.; Ahmed, S.A.; Holladay, S.D.; Gogal, R.M.; Link, L.; Reilly, C.M. Impact of different cell isolation techniques on lymphocyte viability and function. J. Immunoassay Immunochem., 2006, 27, 61-76
15. Zhang, H.; Xie, Y.; Li, W.; Chibbar, R.; Xiong, S.; Xiang, J. CD4(+) T cell-released exosomes inhibit CD8(+) cytotoxic Tlymphocyte responses and antitumor immunity. Cell. Mol. Immunol., 2011, 8, 23-30
16. Preston, C.C.; Maurer, M.J.; Oberg, A.L.; Visscher, D.W.; Kalli, K.R.; Hartmann, L.C.; Goode, E.L.; Knutson, K.L. The Ratios of CD8(+) T Cells to CD4(+)CD25(+) FOXP3(+) and FOXP3(-) T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer. PLoS One, 2013, 8, e80063
17. King, M.A. Detection of dead cells and measurement of cell killing by flow cytometry. J. Immunol. Methods, 2000, 243, 155-166
18. De Rosa, S.C. Vaccine applications of flow cytometry. Methods, 2012, 57, 383-391
19. Alvarez-Barrientos, A.; Arroyo, J.; Canton, R.; Nombela, C.; Sanchez-Perez, M. Applications of flow cytometry to clinical microbiology. Clin. Microbiol. Rev., 2000, 13, 167-195
20. Fulwyler, M.J. Electronic separation of biological cells by volume. Science, 1965, 150, 910-911
21. Barnard, R.M. Flow cytometry: a flexible tool for biomarker research. Bioanalysis, 2012, 4, 2471-2483
22. Watson, D.A.; Brown, L.O.; Gaskill, D.F.; Naivar, M.; Graves, S.W.; Doorn, S.K.; Nolan, J.P.A. flow cytometer for the measurement of Raman spectra. Cytometry A, 2008, 73, 119-128
23. Rasouli, A.; Sun, C.H.; Basu, R.; Wong, B.J. Quantitative assessment of chondrocyte viability after laser mediated reshaping: a novel application of flow cytometry. Lasers Surg. Med., 2003, 32, 3-9
24. Petrunkina A.M., Harrison, R.A. Mathematical analysis of misestimation of cell subsets in flow cytometry: Viability staining revisited. J. Immunol. Methods., 2011, 368, 71-79
25. Mayle, A.; Luo, M.; Jeong, M.; Goodell, M.A. Flow cytometry analysis of murine hematopoietic stem cells. Cytometry A, 2013, 83, 27-37
26. Gonzalez-Diaz, H.; Vilar, S.; Santana, L.; Uriarte, E. Medicinal chemistry and bioinformatics-Current trends in drugs discovery with networks topological indices. Curr. Top. Med. Chem., 2007, 7, 1015-1029
27. Gonzalez-Diaz, H.; Prado-Prado, F.; Ubeira, F.M. Predicting antimicrobial drugs and targets with the MARCH-INSIDE approach. Curr. Top. Med. Chem., 2008, 8, 1676-1690
28. Duardo-Sanchez, A.; Munteanu, C.R.; Riera-Fernandez, P.; Lopez-Diaz, A.; Pazos, A.; Gonzalez-Diaz, H.M.odelling complex metabolic reactions, ecological systems, and financial-legal networks with MIANN models based on Markov-Wiener centralities. J. Chem. Inf. Model., 2014, 54, 16-29
29. Gonzalez-Diaz, H. Bioinformatics and Quantitative Structure-Property Relationship (QSPR) Models. Curr. Bioinform., 2013, 8, 387-389
30. Gonzalez-Diaz, H.; Riera-Fernandez, P.; Pazos, A.; Munteanu, C.R. The Rucker-Markov invariants of complex Bio-Systems: Applications in Parasitology and Neuroinformatics. Biosystems, 2013, 111, 199-207
31. Riera-Fernandez, P.; Munteanu, C.R.; Martin-Romalde, R.; Duardo-Sanchez, A.; Gonzalez-Diaz, H.M.arkov-Randic Indices for QSPR Re-Evaluation of Metabolic, Parasite-Host, Fasciolosis Spreading, Brain Cortex and Legal-Social Complex Networks. Curr. Bioinform., 2013, 8, 401-415
32. Luan, F.; Cordeiro, M.N.D.S.; Alonso, N.; Garcia-Mera, X.; Caamano, O.; Romero-Duran, F.J.; Yanez, M.; Gonzalez-Diaz, H. TOPS-MODE model of multiplexing neuroprotective effects of drugs and experimental-Theoretic study of new 1,3-rasagiline derivatives potentially useful in neurodegenerative diseases. Bioorg. Med. Chem., 2013, 21, 1870-1879
33. Tenorio-Borroto, E.; Penuelas Rivas, C.G.; Vasquez Chagoyan, J.C.; Castanedo, N.; Prado-Prado, F.J.; Garcia-Mera, X.; Gonzalez-Diaz, H. ANN multiplexing model of drugs effect on macrophages; theoretical and flow cytometry study on the cytotoxicity of the antimicrobial drug G1 in spleen. Bioorg. Med. Chem., 2012, 20, 6181-6194
34. Finak, G.; Jiang, W.; Krouse, K.; Wei, C.; Sanz, I.; Phippard, D.; Asare, A.; De Rosa, S.C.; Self, S.; Gottardo, R. High-throughput flow cytometry data normalization for clinical trials. Cytometry A, 2014, 85, 277-286
35. Tenorio-Borroto, E.; Garcia-Mera, X.; Penuelas-Rivas, C.G.; Vasquez-Chagoyan, J.C.; Prado-Prado, F.J.; Castanedo, N.; Gonzalez-Diaz, H. Entropy model for multiplex drug-target interaction endpoints of drug immunotoxicity. Curr. Top. Med. Chem., 2013, 13, 1636-1649
36. Gonzalez-Diaz, H.; Tenorio, E.; Castanedo, N.; Santana, L.; Uriarte, E. 3D QSAR Markov model for drug-induced eosinophilia-Theoretical prediction and preliminary experimental assay of the antimicrobial drug G1. Bioorg. Med. Chem., 2005, 13, 1523-1530
37. Tenorio-Borroto, E.; Penuelas-Rivas, C.G.; Vasquez-Chagoyan, J.C.; Castanedo, N.; Prado-Prado, F.J.; Garcia-Mera, X.; Gonzalez-Diaz, H.M.odel for high-throughput screening of drug immunotoxicity-Study of the anti-microbial G1 over peritoneal macrophages using flow cytometry. Eur. J. Med. Chem., 2014, 72, 206-220
38. Jacques, N.; Vimond, N.; Conforti, R.; Griscelli, F.; Lecluse, Y.; Laplanche, A.; Malka, D.; Vielh P.; Farace, F. Quantification of circulating mature endothelial cells using a whole blood four-color flow cytometric assay. J. Immunol. Methods, 2008, 337, 132-143
39. Ingels, F.M.; Augustijns, P.F. Biological, pharmaceutical, and analytical considerations with respect to the transport media used in the absorption screening system, Caco-2. J. Pharm. Sci., 2003, 92, 1545-1558
40. Coggins, C.R.; Ballantyne, M.; Curvall, M.; Rutqvist, L.E. The in vitro toxicology of Swedish snus. Crit. Rev. Toxicol., 2012, 42, 304-313
41. Gorczyca, W.; Sun, Z.Y.; Cronin, W.; Li, X.; Mau, S.; Tugulea, S. Immunophenotypic pattern of myeloid populations by flow cytometry analysis. Methods Cell Biol., 2011, 103, 221-266
42. Tario Jr., J.D.; Muirhead, K.A.; Pan, D.; Munson, M.E.; Wallace, P.K. Tracking Immune Cell Proliferation and Cytotoxic Potential Using Flow Cytometry. In Flow Cytometry Protocols, Methods Mol. Biol.; Hawley T.S.; Hawley, R.G., Eds. Humana Press, Springer Science+Business Media, LLC: New York, Dordrecht, Heidelberg, London, 2011, 119-164
43. Hill, T.; Lewicki, P. STATISTICS Methods and Applications. A Comprehensive Reference for Science, Industry and Data Mining, StatSoft: Tulsa, 2006
44. Yang, B.; Wang, Y.Q.; Cheng, R.B.; Chen, J.L.; Chen, J.; Jia, L.T.; Zhang, R.S. Induction of Cytotoxicity and Apoptosis in Human Gastric Cancer Cell SGC-7901 by Isovaltrate Acetoxyhydrin Isolated from Patrinia heterophylla Bunge Involves a Mitochondrial Pathway and G2/M Phase Cell Cycle Arrest. Asian Pac. J. Cancer Prev., 2013, 14, 6481-6486
45. Majchrzak, A.; Witkowska, M.; Medra, A.; Zwolinska, M.; Bogusz, J.; Cebula-Obrzut, B.; Darzynkiewicz, Z.; Robak, T.; Smolewski, P. In vitro cytotoxicity of ranpirnase (onconase) in combination with components of R-CHOP regimen against diffuse large B cell lymphoma (DLBCL) cell line. Postepy Hig. Med. Dosw. (Online), 2013, 67, 1166-1172
46. Wang, X.; Xia, Y.; Liu, L.; Liu, M.; Gu, N.; Guang, H.; Zhang, F. Comparison of MTT assay, flow cytometry, and RT-PCR in the evaluation of cytotoxicity of five prosthodontic materials. J. Biomed. Mater. Res. B Appl. Biomater., 2010, 95, 357-364
47. Al-Jamal, K.T.; Kostarelos, K. Assessment of cellular uptake and cytotoxicity of carbon nanotubes using flow cytometry. Methods Mol. Biol., 2010, 625, 123-134
48. Perez Machado, G.; Gonzalez Borroto, J.I.; Castanedo, N.; Creus, A.; Marcos, R. In vitro genotoxicity testing of the furylethylene derivative UC-245 in human cells. Mutagenesis., 2004, 19, 75-80
49. Blondeau, J.M.; Castanedo, N.; Gonzalez, O.; Mendina, R.; Silveira, E. In vitro evaluation of G1: a novel antimicrobial compound. Int. J. of Antimicrob. Agents, 1999, 11, 163-166
50. Marrero-Ponce Y, Castillo-Garit, J.A.; Olazabal, E.; Serrano, H.S.; Morales, A.; Castanedo, N.; Ibarra-Velarde, F.; Huesca-Guillen, A.; Sanchez, A.M.; Torrens, F.; Castro, E.A. Atom, atom-type and total molecular linear indices as a promising approach for bioorganic and medicinal chemistry: theoretical and experimental assessment of a novel method for virtual screening and rational design of new lead anthelmintic. Bioorg. Med. Chem., 2005, 13, 1005-1020
51. McGowan, P., Nelles, N.; Wimmer, J.; Williams, D.; Wen, J.; Li, M.; Ewton, A.; Curry, C.; Zu, Y.; Sheehan, A.; Chang, C.C. Differentiating Between Burkitt Lymphoma and CD10+ Diffuse Large B-Cell Lymphoma: The Role of Commonly Used Flow Cytometry Cell Markers and the Application of a Multiparameter Scoring System. Am. J. Clin. Pathol., 2012, 137, 665-670
52. Shin, K.J., Wall, E.A.; Zavzavadjian, J.R.; Santat, L.A.; Liu, J.; Hwang, J.I.; Rebres, R.; Roach, T.; Seaman, W.; Simon, M.I.; Fraser, I.D. A single lentiviral vector platform for microRNAbased conditional RNA interference and coordinated transgene expression. Proc. Natl. Acad. Sci. USA, 2006, 103, 13759-13764
53. Savaşan, S., Buck, S.; Ozdemir, O.; Hamre, M.; Asselin, B.; Pullen, J.; Ravindranath, Y. Evaluation of cytotoxicity by flow cytometric drug sensitivity assay in childhood T-cell acute lymphoblastic leukemia. Leuk. Lymphoma, 2005, 46, 833-840
54. Box, G.E.P.; Jenkins, G.M. Time series analysis forecasting and control. Holden-Day: San Francisco, 1970
55. Alonso, N.; Caamano, O.; Romero-Duran, F.J.; Luan, F.; Dias Soeiro Cordeiro, M.N.D.S.; Yanez, M.; Gonzalez-Diaz, H.; Garcia-Mera, X. Model for high-throughput screening of multi-target drugs in chemical neurosciences: Synthesis, assay and theoretic study of rasagiline carbamates. ACS Chem. Neurosci., 2013, 4, 1393-1403
56. Speck-Planche, A.; Kleandrova, V.V.; Cordeiro, M.N.D.S. Chemoinformatics for rational discovery of safe antibacterial drugs: simultaneous predictions of biological activity against streptococci and toxicological profiles in laboratory animals. Bioorg. Med. Chem., 2013, 21, 2727-2732
57. Speck-Planche, A.; Kleandrova, V.V.; Luan, F.; Cordeiro, M.N.D.S. Chemoinformatics in multi-target drug discovery for anti-cancer therapy: in silico design of potent and versatile antibrain tumor agents. Anticancer Agents Med. Chem., 2012, 12, 678-685
58. Speck-Planche, A.; Kleandrova, V.V.; Luan, F.; Cordeiro, M.N.D.S. Chemoinformatics in anti-cancer chemotherapy: multitarget QSAR model for the in silico discovery of anti-breast cancer agents. Eur. J. Pharm. Sci., 2012, 47, 273-279
59. Speck-Planche, A.; Kleandrova, V.V.; Luan, F.; Cordeiro, M.N.D.S. Rational drug design for anti-cancer chemotherapy: multi-target QSAR models for the in silico discovery of anticolorectal cancer agents. Bioorg. Med. Chem., 2012, 20, 4848-4855
60. Speck-Planche, A.; Kleandrova, V.V.; Luan, F.; Cordeiro, M.N.D.S. Multi-target drug discovery in anti-cancer therapy: fragment-based approach toward the design of potent and versatile anti-prostate cancer agents. Bioorg. Med. Chem., 2011, 19, 6239-6244
61. Speck-Planche, A.; Kleandrova, V.V.; Luan, F.; Cordeiro, M.N.D.S. Multi-target inhibitors for proteins associated with Alzheimer: in silico discovery using fragment-based descriptors. Curr. Alzheimer Res., 2013, 10, 117-124
62. Speck-Planche, A.; Kleandrova, V.V.; Luan, F.; Cordeiro, M.N.D.S. In silico discovery and virtual screening of multi-target inhibitors for proteins in Mycobacterium tuberculosis. Comb. Chem. High Throughput Screen., 2012, 15, 666-673
63. Speck-Planche, A.; Kleandrova, V.V. In silico design of multitarget inhibitors for C-C chemokine receptors using substructural descriptors. Mol. Divers., 2012, 16, 183-191
64. Gerets, H.H.; Dhalluin, S.; Atienzar, F.A. Multiplexing cell viability assays. Methods Mol. Biol., 2011, 740, 91-101
65. Gaulton, A.; Bellis, L.J.; Bento, A.P.; Chambers, J.; Davies, M.; Hersey, A.; Light, Y.; McGlinchey, S.; Michalovich, D.; Al-Lazikani, B.; Overington, J.P. ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res., 2012, 40, D1100-1107
66. Heikamp, K.; Bajorath, J. Large-scale similarity search profiling of ChEMBL compound data sets. J. Chem. Inf. Model., 2011, 51, 1831-1839
67. Tenorio-Borroto, E.; Penuelas-Rivas, C.G.; Vasquez-Chagoyan, J.C.; Prado-Pradoa, F.J.; Garcia-Mera, X.; Gonzalez-Diaz, H. Immunotoxicity, flow cytometry, and chemoinformatics: review, bibliometric analysis, and new QSAR model of drug effects over macrophages. Curr. Top. Med. Chem., 2012, 12, 1815-1833
68. Patankar, S.J.; Jurs, P.C. Classification of inhibitors of protein tyrosine phosphatase 1B using molecular structure based descriptors. J. Chem. Inf. Comput. Sci., 2003, 43, 885-899
69. Garcia-Garcia, A.; Galvez, J.; de Julian-Ortiz, J.V.; Garcia-Domenech, R.; Munoz, C.; Guna, R.; Borras, R. New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method. J. Antimicrob. Chemother., 2004, 53, 65-73
70. Le-Thi-Thu, H.; Casanola-Martin, G.M.; Marrero-Ponce, Y.; Rescigno, A.; Saso, L.; Parmar, V.S.; Torrens, F.; Abad, C. Novel coumarin-based tyrosinase inhibitors discovered by OECD principles-validated QSAR approach from an enlarged, balanced database. Mol. Divers., 2011, 15, 507-520
71. Marrero-Ponce, Y.; Machado-Tugores, Y.; Pereira, D.M.; Escario, J.A.; Barrio, A.G.; Nogal-Ruiz, J.J.; Ochoa, C.; Aran, V.J.; Martinez-Fernandez, A.R.; Sanchez, R.N.; Montero-Torres, A.; Torrens, F.; Meneses-Marcel, A. A computer-based approach to the rational discovery of new trichomonacidal drugs by atom-type linear indices. Curr. Drug Discov. Technol., 2005, 2, 245-265
72. Casanola-Martin, G.M.; Marrero-Ponce, Y.; Khan, M.T.; Ather, A.; Sultan, S.; Torrens, F.; Rotondo, R. TOMOCOMD-CARDD descriptors-based virtual screening of tyrosinase inhibitors: evaluation of different classification model combinations using bond-based linear indices. Bioorg. Med. Chem., 2007, 15, 1483-1503
73. Casanola-Martin, G.M.; Marrero-Ponce, Y.; Tareq Hassan Khan, M.; Torrens, F.; Perez-Gimenez, F.; Rescigno, A. Atom-and bondbased 2D TOMOCOMD-CARDD approach and ligand-based virtual screening for the drug discovery of new tyrosinase inhibitors. J. Biomol. Screen., 2008, 13, 1014-1024
74. Casanola-Martin, G.M.; Marrero-Ponce, Y.; Khan, M.T.; Khan, S.B.; Torrens, F.; Perez-Jimenez, F.; Rescigno, A.; Abad, C. Bondbased 2D quadratic fingerprints in QSAR studies: virtual and in vitro tyrosinase inhibitory activity elucidation. Chem. Biol. Drug Des., 2010, 76, 538-545
75. Estrada, E.; Uriarte, E.; Montero, A.; Teijeira, M.; Santana, L.; De Clercq, E. A novel approach for the virtual screening and rational design of anticancer compounds. J. Med. Chem., 2000, 43, 1975-1985
76. Estrada, E.; Peña, A. In silico studies for the rational discovery of anticonvulsant compounds. Bioorg. Med. Chem., 2000, 8, 2755-2770
77. Estrada, E.; Gutierrez, Y.; Gonzalez, H.M.odeling diamagnetic and magnetooptic properties of organic compounds with the TOSSMODE approach. J. Chem. Inf. Comput. Sci., 2000, 40, 1386-1399
78. Estrada, E. On the topological sub-structural molecular design (TOSS-MODE) in QSPR/QSAR and drug design research. SAR QSAR Environ. Res., 2000, 11, 55-73
79. Estrada, E.; Uriarte, E. Recent advances on the role of topological indices in drug discovery research. Curr. Med. Chem., 2001, 8, 1573-1588
80. Estrada, E.; Vilar, S.; Uriarte, E.; Gutierrez, Y. In silico studies toward the discovery of new anti-HIV nucleoside compounds with the use of TOPS-MODE and 2D/3D connectivity indices. 1. Pyrimidyl derivatives. J. Chem. Inf. Comput. Sci., 2002, 42, 1194-1203
81. Estrada, E.; Quincoces, J.A.; Patlewicz, G. Creating molecular diversity from antioxidants in Brazilian propolis. Combination of TOPS-MODE QSAR and virtual structure generation. Mol. Divers., 2004, 8, 21-33
82. Estrada, E.; Uriarte, E.; Molina, E.; Simon-Manso, Y.; Milne, G.W. An integrated in silico analysis of drug-binding to human serum albumin. J. Chem. Inf. Model., 2006, 46, 2709-2724
83. Estrada, E.; Molina, E.; Nodarse, D.; Uriarte, E. Structural contributions of substrates to their binding to P-Glycoprotein. A TOPS-MODE approach. Curr. Pharm. Des., 2010, 16, 2676-2709
84. Pisco, L.; Kordian, M.; Peseke, K.; Feist, H.; Michalik, D.; Estrada, E.; Carvalho, J.; Hamilton, G.; Rando, D.; Quincoces, J. Synthesis of compounds with antiproliferative activity as analogues of prenylated natural products existing in Brazilian propolis. Eur. J. Med. Chem., 2006, 41, 401-407
85. Estrada, E.; Uriarte, E. Quantitative structure-toxicity relationships using TOPS-MODE. 1. Nitrobenzene toxicity to Tetrahymena pyriformis. SAR QSAR Environ. Res., 2001, 12, 309-324
86. Estrada, E.; Molina, E.; Uriarte, E. Quantitative structure-toxicity relationships using TOPS-MODE. 2. Neurotoxicity of a noncongeneric series of solvents. SAR QSAR Environ. Res., 2001, 12, 445-459
87. Estrada, E.; Uriarte, E.; Gutierrez, Y.; Gonzalez-Diaz, H. Quantitative structure-toxicity relationships using TOPS-MODE. 3. Structural factors influencing the permeability of commercial solvents through living human skin. SAR QSAR Environ. Res., 2003, 14, 145-163
88. Estrada, E.; Patlewicz, G.; Gutierrez, Y. From knowledge generation to knowledge archive. A general strategy using TOPSMODE with DEREK to formulate new alerts for skin sensitization. J. Chem. Inf. Comput. Sci., 2004, 44, 688-698
89. Marzaro, G.; Chilin, A.; Guiotto, A.; Uriarte, E.; Brun, P.; Castagliuolo, I.; Tonus, F.; Gonzalez-Diaz, H. Using the TOPSMODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors. Eur. J. Med Chem., 2011, 46, 2185-2192
90. Molina, E.; Sobarzo-Sánchez, E.; Speck-Planche, A.; Matos, M.J. Monoamino Oxidase A: an interesting pharmacological target for the development of multi-target QSAR. Mini Rev. Med. Chem., 2012, 12, 947-958
91. Marrero-Ponce, Y.; Siverio-Mota, D.; Galvez-Llompart, M.; Recio, M.C.; Giner, R.M.; Garcia-Domenech, R.; Torrens, F.; Arán, V.J.; Cordero-Maldonado, M.L.; Esguera, C.V.; de Witte, P.A.; Crawford, A.D. Discovery of novel anti-inflammatory drug-like compounds by aligning in silico and in vivo screening: the nitroindazolinone chemotype. Eur. J. Med. Chem., 2011, 46, 5736-5753
92. Suenderhauf, C.; Hammann, F.; Maunz, A.; Helma, C.; Huwyler, J. Combinatorial QSAR modeling of human intestinal absorption. Mol. Pharmceutics, 2011, 8, 213-224
93. Jaiswal, K.; Naik, P.K. Distinguishing compounds with anticancer activity by ANN using inductive QSAR descriptors. Bioinformation, 2008, 2, 441-451
94. Gonzalez-Diaz, H.; Agüero-Chapin, G.; Varona-Santos, J.; Molina, R.; de la Riva, G.; Uriarte, E. 2D RNA-QSAR: assigning ACC oxidase family membership with stochastic molecular descriptors; isolation and prediction of a sequence from Psidium guajava L. Bioorg. Med. Chem. Lett., 2005, 15, 2932-2937
95. Van Waterbeemd, H. Chemometric methods in molecular design, Wiley-VCH: New York, 1995
96. Speck-Planche, A.; Kleandrova, V.V.; Luan, F.; Cordeiro, M.N.D.S. Fragment-based QSAR model toward the selection of versatile antisarcoma leads. Eur. J. Med. Chem., 2011, 46, 5910-5916
97. Yuan, J.; Pu, Y.; Yin, L. Predicting carcinogenicity and understanding the carcinogenic mechanism of N-nitroso compounds using a TOPS-MODE approach. Chem. Res. Toxicol., 2011, 24, 2269-2279
98. Gonzalez Borroto, J.I.; Perez Machado G.; Creus, A.; Marcos, R. Comparative genotoxic evaluation of 2-furylethylenes and 5-nitrofurans by using the comet assay in TK6 cells. Mutagenesis, 2005, 20, 193-197
99. Ma, Q.; Zhang, K.; Guin, S.; Zhou, Y.Q.; Wang, M.H. Deletion or insertion in the first immunoglobulin-plexin-transcription (IPT) domain differentially regulates expression and tumorigenic activities of RON receptor Tyrosine Kinase. Mol. Cancer, 2010, 9, 307
100. OECD-team. Guidance document on using cytotoxicity tests to estimate starting doses for acute oral systemic toxicity tests. OECD Series on Testing and Assessment, 2010, 20, 1-54
101. Love, P.E.; Bhandoola, A. Signal integration and crosstalk during thymocyte migration and emigration. Nat. Rev. Immunol., 2011, 11, 469-477
102. Nitta, T.; Murata, S.; Ueno, T.; Tanaka, K.; Takahama, Y. Thymic microenvironments for T-cell repertoire formation. Adv. Immunol., 2008, 99, 59-94
103. Anderson, G.; Lane, P.J.; Jenkinson, E.J. Generating intrathymic microenvironments to establish T-cell tolerance. Nat. Rev. Immunol., 2007, 7, 954-963
104. Coakley, E.; Reeves, J.D.; Huang, W.; Mangas-Ruiz, M.; Maurer, I.; Harskamp, A.M.; Gupta, S.; Lie, Y.; Petropoulos, C.J.; Schuitemaker, H.; van 't Wout, A.B. Comparison of human immunodeficiency virus type 1 tropism profiles in clinical samples by the Trofile and MT-2 assays. Antimicrob. Agents Chemother., 2009, 53, 4686-4693
105. Urano, E.; Kariya, Y.; Futahashi, Y.; Ichikawa, R.; Hamatake, M.; Fukazawa, H.; Morikawa, Y.; Yoshida, T.; Koyanagi, Y.; Yamamoto, N.; Komano, J. Identification of the P-TEFb complexinteracting domain of Brd4 as an inhibitor of HIV-1 replication by functional cDNA library screening in MT-4 cells. FEBS Lett., 2008, 582, 4053-4058
106. Stephen, T.L.; Wilson, B.S.; Laufer, T.M. Subcellular distribution of Lck during CD4 T-cell maturation in the thymic medulla regulates the T-cell activation threshold. Proc. Natl. Acad. Sci. USA, 2012, 109, 7415-7420
107. Dai, P.; Liu, X.; Li, Q.W. Function of the Lck and Fyn in T cell development. Yi Chuan, 2012, 34, 289-295
108. Borowiec, M.; Liew, C.W.; Thompson, R.; Boonyasrisawat, W.; Hu, J.; MLynarski, W.M.; El Khattabi, I.; Kim, S.H.; Marselli, L.; Rich, S.S.; Krolewski, A.S.; Bonner-Weir, S.; Sharma, A.; Sale, M.; Mychaleckyj, J.C.; Kulkarni, R.N.; Doria, A. Mutations at the BLK locus linked to maturity onset diabetes of the young and betacell dysfunction. Proc. Natl. Acad. Sci. USA, 2009, 106, 14460-14465
109. Castillejo-Lopez, C.; Delgado-Vega, A.M.; Wojcik, J.; Kozyrev, S.V.; Thavathiru, E.; Wu, Y.Y.; Sánchez, E.; Pöllmann, D.; Lopez-Egido, J.R.; Fineschi, S.; Dominguez, N.; Lu, R.; James, J.A.; Merrill, J.T.; Kelly, J.A.; Kaufman, K.M.; Moser, K.L.; Gilkeson, G.; Frostegård, J.; Pons-Estel, B.A.; D'Alfonso, S.; Witte, T.; Callejas, J.L.; Harley, J.B.; Gaffney, P.M.; Martin, J.; Guthridge, J.M.; Alarcon-Riquelme, M.E. Genetic and physical interaction of the B-cell systemic lupus erythematosus-associated genes BANK1 and BLK. Ann. Rheum. Dis., 2012, 71, 136-142
110. Gourh, P.; Agarwal, S.K.; Martin, E.; Divecha, D.; Rueda, B.; Bunting, H.; Assassi, S.; Paz, G.; Shete, S.; McNearney, T.; Draeger, H.; Reveille, J.D.; Radstake, T.R.; Simeon, C.P.; Rodriguez, L.; Vicente, E.; Gonzalez-Gay, M.A.; Mayes, M.D.; Tan, F.K.; Martin, J.; Arnett, F.C. Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations. J. Autoimmun., 2010, 34, 155-162
111. Mihara, S.; Suzuki, N. Role of Txk, a member of the Tec family of tyrosine kinases, in immune-inflammatory diseases. Int. Rev. Immunol., 2007, 26, 333-348
112. Maruyama, T.; Nara, K.; Yoshikawa, H.; Suzuki, N. Txk, a member of the non-receptor tyrosine kinase of the Tec family, forms a complex with poly(ADP-ribose) polymerase 1 and elongation factor 1alpha and regulates interferon-gamma gene transcription in Th1 cells. Clin. Exp. Immunol., 2007, 147, 164-175.